Expert evaluation imagery representing structured training and evaluation data for pharma AI.

Pharma AI data · · 7 min read

Expert network vs. expert data vendor: which one your pharma AI program needs

Acumen Editorial · Updated November 21, 2026

Expert networks are moving into AI tools. On May 5, 2026, Guidepoint launched an MCP server for Claude that brings more than 100,000 expert interview transcripts into AI research workflows, with over 5,000 added each month. On November 12, 2026, GLG announced that its Expert Content Library now connects to Rogo, an AI platform for financial services.

At the same time, spending on expert data for AI keeps climbing. Anthropic's amended S-1, filed November 2, 2026, reports a $757 million increase in vendor costs for data quality and performance evaluation services in the nine months to September 30, as summarized by FourWeekMBA.

Both trends put "experts" and "AI" in the same sentence. They are different purchases. If you run insights, medical affairs or an AI team inside a pharma company, buying the wrong one wastes a quarter. Here is how we tell them apart.

What does an expert network actually deliver?

An expert network connects you with people who know a market. You book a call with a hospital pharmacist or a payer medical director, ask your questions and get an hour of their judgment. Many networks also sell libraries of past calls as transcripts.

The output is built for a human reader. It is conversational, it answers the questions one client asked, and it reflects one expert's view on one day. Networks invest heavily in compliance for that use. Guidepoint, for example, describes its library as compliance reviewed, with each AI answer linked back to its source transcript and an audit trail.

That is valuable for a brand team scoping a market or an investor preparing for earnings. Guidepoint's own example is a healthcare investor collecting physician perspectives on a drug class.

What does an expert data vendor deliver?

An expert data vendor commissions verified experts to produce data in a defined format for a model. In healthcare and pharma, public job posts from expert data platforms describe the work like this:

  • Case authoring. A physician writes a case from practice: presentation, workup, constraints and a reference answer the model is graded against.
  • Rubrics. Experts write criteria that score a model's response, such as whether a differential is ordered sensibly or a guideline actually applies to this patient.
  • Preference pairs. An expert compares two model answers to the same prompt and picks the better one, with a reason.
  • Adversarial scenarios. Experts design difficult cases meant to expose unsafe or wrong recommendations.

The output is built for a training pipeline or an evaluation harness. Each item follows a schema, carries specialty metadata and is reviewed by more than one expert. Rights to use it for training are part of the contract from the start.

How do they compare side by side?

FactorExpert networkExpert data vendor
Primary buyerInsights, strategy, investorsAI/ML, post-training, evaluation leads
Unit of outputA call or a transcriptA labeled item: case, rubric, preference pair
FormatFree-text conversationStructured schema, ready for a pipeline
Who sets the questionsOne client, in the momentA task specification written before work begins
Quality controlCompliance review of contentMulti-expert review and adjudication
RightsLicensed for reading and searchCommissioned for training and evaluation
Best forMarket context, decision supportFine-tuning, RLHF, benchmarks, red teaming

Can expert network transcripts be used to train a model?

Sometimes, but do not assume it. A transcript library license may cover reading, search and retrieval inside an assistant. That is different from using the text as training data or as the ground truth in an evaluation. Ask the network in writing what its license permits and whether the experts consented to that use.

Even where rights are clear, transcripts are weak training material. They hold opinions without reference answers. Nothing tells a model which statement was right. The questions were set by whoever paid for the call, so coverage of specialties, indications and edge cases is uneven.

Evaluation makes the gap obvious. OpenAI's HealthBench grades responses against conversation-specific rubrics written by 262 physicians. That depth comes from commissioned work, not from repurposed calls.

Why does the difference matter more now?

Because HCPs are already asking AI tools clinical questions. IQVIA's November 10, 2026 analysis, drawing on a survey of more than 23,000 HCPs in 34 countries, reports that 80% used AI tools as of June 2026. In its review of more than 2,000 anonymized prompts, nearly a third had a patient-specific element.

If your company builds or tests the tools that answer those questions, you need data that shows what a correct, guideline-concordant answer looks like for a specific patient. That is reference-answer work, written and checked by specialists.

Regulators point the same way. FDA's January 2025 draft guidance on AI-enabled device software asks sponsors to describe how data was collected, cleaned and processed, and to keep test data independent. A stack of licensed call transcripts is hard to describe that way. A commissioned dataset with a written specification and a review log is not.

Checklist: which one do you need?

Use this before you sign either contract:

  • Is a person or a model consuming the output? A person reading for context points to an expert network. A model learning or being scored points to expert data.
  • Do you need a right answer? If each item needs a reference answer or a score, you need commissioned expert data.
  • Do you need coverage you can prove? Specialty, indication and difficulty quotas are set in a task specification, not by a run of client calls.
  • Are training rights explicit? Get written confirmation that the content may be used to train or evaluate models, and that experts agreed.
  • How many experts touch each item? One voice is fine for a briefing. Training and evaluation data needs independent review and adjudication.
  • Can you document it? Ask for provenance, credential checks and a review log you could hand to a regulator or procurement team.
  • Who is the expert? Verify license and specialty for every contributor, and match them to the clinical area of the task.

Most pharma organizations will buy both. The network informs strategy. The expert data trains and tests the AI that strategy depends on.

What should you ask an expert data vendor?

1. How do you verify each contributor's license and specialty?

2. Who writes the task specification, and can we review it?

3. How many experts review each item, and how are disagreements resolved?

4. What rights do we receive, and are they exclusive?

5. What documentation comes with delivery?

6. Can we see a sample in our own format before we commit?

For a longer list, see what to ask a scientific expert data vendor.

How Acumen helps

We are an expert data vendor built only for healthcare, life sciences and pharma. Our market research data for AI service gives pharma teams verified HCP, patient and payer data structured for training and evaluation. For model builders, our custom expert data collection covers case authoring, rubrics and preference data matched by specialty.

Every contributor is verified, every item is reviewed and adjudicated, and every delivery ships with documentation and clear training rights.

Request a sample dataset Schedule a conversation

FAQ

What is the difference between an expert network and an expert data vendor?

An expert network sells access to experts' opinions through calls and transcript libraries that people read for context. An expert data vendor commissions verified experts to produce structured items for AI, such as cases with reference answers, scoring rubrics and preference pairs. The first informs human decisions. The second trains and evaluates models.

Can expert network transcripts be used to train AI models?

Only if the license and expert consent explicitly allow it, so ask in writing. Many transcript licenses are written for reading, search and retrieval. Even with rights, transcripts make weak training data. They contain opinions without reference answers, and their topic coverage follows past client questions rather than a planned specification.

Are expert network MCP servers the same as AI training data?

No. An MCP server, such as the one Guidepoint launched for Claude in May 2026, lets an AI assistant search and cite transcripts while a person works. That is retrieval for research. Training data changes the model itself, and evaluation data scores it. Both need different formats, rights and review.

What kind of expert data do pharma AI teams buy?

Common purchases include physician-written cases with reference answers, rubrics that grade clinical reasoning, pairwise preference judgments, adversarial red-team scenarios and structured HCP, patient and payer responses for insights models. Each is specialty matched, reviewed by more than one expert and delivered in a schema ready for a training or evaluation pipeline.

Why does documentation matter when buying expert data?

Regulated buyers increasingly need to explain where AI data came from. FDA's January 2025 draft guidance on AI-enabled device software asks sponsors to describe data collection, cleaning and processing, and to keep test data independent. Credential checks, task specifications and review logs make that description possible during procurement or regulatory review.

Should a pharma company use an expert network or an expert data vendor?

Usually both, for different jobs. Use an expert network when people need fast market context, such as scoping an indication or preparing a launch. Use an expert data vendor when a model needs to learn or be scored, such as fine-tuning an assistant or building a benchmark. Keep the contracts and rights separate.

From the Acumen archive. Explore expert data and Healthcare & Pharma.

← Back to Insights